A reduction in the level of a new enzymatic assay--a phenyl valerate hydrolase (PVH)--has been found during the clinical evolution of toxic neuropathies (as almitrine-bismetilate ones) as well as alcoholic or diabetic neuropathies. The substrate and the enzymatic function are different from those used by M.K. Johnson for NTE. The method follows procedures comparable to NTE (differential determination after inhibition by paraoxon and by paraoxon plus mipafox or DFP). It may be useful to test possible neurotoxicity of drugs and chemicals.

Download full-text PDF

Source

Publication Analysis

Top Keywords

[lymphocyte phenylvaleric
4
phenylvaleric acid
4
acid hydroxylase
4
hydroxylase activity
4
activity l-pvh
4
l-pvh marker
4
marker peripheral
4
peripheral neurotoxicity]
4
neurotoxicity] reduction
4
reduction level
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!